Matrix assisted laser desorption ionization-time of flight-mass spectrometry

  • 文章类型: Journal Article
    背景:目前,目前尚无有效的措施来预测小细胞肺癌(SCLC)化疗的疗效.我们期望开发一种在临床实践中有效预测SCLC化疗疗效和预后的方法,以便为个体患者提供更有针对性的治疗方案。
    方法:我们采用基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF-MS)和ClinProTools系统检测154例标准化疗疗效不同的SCLC患者的血清样本,并分析SCLC患者的不同肽/蛋白,以发现与化疗疗效相关的预测肿瘤标志物。10个肽/蛋白峰在两组间有显著差异。
    结果:从训练组开发了由四种肽/蛋白质组成的遗传算法模型,以分离具有不同化疗疗效的患者。其中,三种肽/蛋白(m/z3323.35,6649.03和6451.08)在疾病进展组中高表达,而m/z4283.18的肽/蛋白在疾病反应组中高表达。分类器在验证组中表现出91.4%(53/58)的准确度。生存分析显示,疾病缓解组30例SCLC患者的中位无进展生存期(PFS)为9.0个月;疾病进展组28例,中位PFS为3.0个月,差异有统计学意义(χ2=46.98,P<0.001)。两组的中位总生存期(OS)分别为13.0个月和7.0个月,差异有统计学意义(χ2=40.64,P<0.001)。
    结论:这些肽/蛋白可作为潜在的生物学标志物,用于预测接受标准方案化疗的SCLC患者的疗效和预后。
    BACKGROUND: Currently, no effective measures are available to predict the curative efficacy of small-cell lung cancer (SCLC) chemotherapy. We expect to develop a method for effectively predicting the SCLC chemotherapy efficacy and prognosis in clinical practice in order to offer more pertinent therapeutic protocols for individual patients.
    METHODS: We adopted matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) and ClinPro Tools system to detect serum samples from 154 SCLC patients with different curative efficacy of standard chemotherapy and analyze the different peptides/proteins of SCLC patients to discover predictive tumor markers related to chemotherapy efficacy. Ten peptide/protein peaks were significantly different in the two groups.
    RESULTS: A genetic algorithm model consisting of four peptides/proteins was developed from the training group to separate patients with different chemotherapy efficacies. Among them, three peptides/proteins (m/z 3323.35, 6649.03 and 6451.08) showed high expression in the disease progression group, whereas the peptide/protein at m/z 4283.18 was highly expressed in the disease response group. The classifier exhibited an accuracy of 91.4% (53/58) in the validation group. The survival analysis showed that the median progression-free survival (PFS) of 30 SCLC patients in disease response group was 9.0 months; in 28 cases in disease progression group, the median PFS was 3.0 months, a statistically significant difference (χ2 = 46.98, P < 0.001). The median overall survival (OS) of the two groups was 13.0 months and 7.0 months, a statistically significant difference (χ2 = 40.64, P < 0.001).
    CONCLUSIONS: These peptides/proteins may be used as potential biological markers for prediction of the curative efficacy and prognosis for SCLC patients treated with standard regimen chemotherapy.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    Fusarium oxysporum f. sp. radicis-lycopersici (FORL) leading to fusarium crown and root rot is considered one of the most destructive tomato soilborne diseases occurring in greenhouse and field crops. In this study, response to FORL infection in tomato roots was investigated by differential proteomics in susceptible (Monalbo) and resistant (Momor) isogenic tomato lines, thus leading to identify 33 proteins whose amount changed depending on the pathogen infection, and/or on the two genotypes. FORL infection induced accumulation of pathogen-related proteins (PR proteins) displaying glucanase and endochitinases activity or involved in redox processes in the Monalbo genotype. Interestingly, the level of the above mentioned PR proteins was not influenced by FORL infection in the resistant tomato line, while other proteins involved in general response mechanisms to biotic and/or abiotic stresses showed significant quantitative differences. In particular, the increased level of proteins participating to arginine metabolism and glutathione S-transferase (GST; EC 2.5.1.18) as well as that of protein LOC544002 and phosphoprotein ECPP44-like, suggested their key role in pathogen defence.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号